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OBJECTIVES: To investigate hypoxia and sleep disordered breathing in infants with congenital heart disease.
METHODS: Prospective study. In-hospital full polysomnography was performed on 14 infants with congenital heart disease, age 
7 ±1 months, and in 7 normal infants, age 10 ±2 months. Congenital heart disease infants were classified as acyanotic (n=7) or 
cyanotic (n=7). 
RESULTS: Nutritional status, assessed by the Gomez classification and expressed as % weight for age, was 70 ±7, 59 ±11 and 
94 ±16 in the acyanotic, cyanotic congenital heart disease and control infants, respectively (p<0.001). The respiratory disturbance 
index (AHI, events per hour) was [median (25-75%)]: 2.5 (1.0–3.4), 2.4 (1.5–3.1) and 0.7 (0.7–0.9) in acyanotic, cyanotic CHD 
infants and controls, respectively (p=0.013). Almost all congenital heart disease infants (11 out of 14) and only one control infant 
had an AHI >1 event/hour. The minimum oxygen saturation was 79% (74–82), 73% (57-74) and 90% (90–91) in the acyanotic, 
cyanotic congenital heart disease infants and controls, respectively (p <0.001). The arousal index (events/hour) was similar among 
the three groups at 8.4 ±2.4, 10.3 ±8.7 and 6.5 ±3, respectively (p=0.451). 
CONCLUSIONS: Infants with congenital heart disease frequently present with sleep-disordered breathing associated with oxygen 
desaturations but not arousals. Therefore, sleep may represent a significant burden to infants with congenital heart disease. 
KEYWORDS: Sleep disorders; Sleep apnea syndromes; Infant; Congenital heart defects; Polysomnography.
INTRODUCTION
The incidence of congenital heart disease (CHD) among 
live-born infants averages from 4 to 9 per thousand (0.4-
0.9%). There are approximately 1.5 million new cases per year 
worldwide1. Recent advances allow accurate anatomical and 
physiological cardiac diagnoses that are important for reparative 
surgery.1 Because of its impact on survival, there is a growing 
interest in the many clinical features of infants with CHD.
The central fetal circulation changes dramatically 
at birth. Two distinct circulations in series replace the 
inefficient separation of the oxygen uptake and delivery 
circulations of the fetus after birth. CHD may cause 
decreased cardiac output and heart failure. Moreover, 
systemic hypoxia and cyanosis, resulting from the mixture 
of oxygenated (pulmonary venous) and desaturated (system 
venous) blood shunting through the systemic circulation, 
is common in CHD patients. Although there is some 
controversy about nomenclature in pediatric cardiology, 
infants with congenital heart disease are classified as 
acyanotic or cyanotic on the basis of their aortic SaO2 levels 
at the time of cardiac catheterization (greater or less than 
90% SaO2, respectively).2
Infants spend a significant amount of time sleeping, 
a period in which respiratory instability and oxygen 
desaturation may occur.3 Sleep apnea occurs in children of 
all ages, from neonates to adolescents. It is more frequent in 
the preschool age group due to adenotonsillar hypertrophy. 
The prevalence of obstructive sleep apnea in toddlers and 1206
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preschoolers is conservatively estimated to be 1-3%.4 Sleep 
apnea can result in serious morbidity, and complications 
such as failure to thrive and asymptomatic degree of 
pulmonary hypertension may be common.5 There is 
evidence that patients with CHD frequently present oxygen 
desaturation during sleep;5 however, there are no systematic 
data regarding sleep in these infants. Adults with congestive 
heart disease frequently present central sleep apnea6, 
raising the possibility that infants with congenital heart 
disease may also present central sleep apnea. There is also 
evidence for interaction of obstructive sleep apnea with other 
cardiovascular pathologies7 and it is known that pharyngeal 
dimensions are critical with regard to airway obstruction.8
The objective of our study was to investigate sleep-
disordered breathing as well as the characteristics of sleep 
architecture in infants with CHD. To this end, we performed 
in-hospital full polysomnography on infants with CHD, 
who were grouped according to the presence or absence of 
hypoxia while they were awake. In addition, a control group 
of healthy infants was also studied. 
METHODS
We studied a total of 21 infants (age 6-12 months), 
including 14 infants with CHD and 7 normal controls. 
The CHD infants were classified as acyanotic (n=7) or 
cyanotic (n=7). The CHD infants were recruited from the 
Pediatric Heart Unit of our hospital (Instituto do Coração 
do Hospital das Clínicas da Universidade de São Paulo) 
during admission for surgical evaluation. Patients who 
had undergone previous cardiac surgery, those who had 
neurological or infectious diseases, those requiring oxygen, 
premature infants and those with associated syndromes 
(such as Down syndrome) were excluded. Healthy control 
infants were recruited from a nursery school associated with 
our institution. These healthy infants were born at term and 
had no history of lower respiratory tract illness. The infants’ 
nutritional status was assessed by the Gomez classification9, 
using weight for age. Briefly, values of 90-110%, 75-89%, 
60-74% and <60% are considered normal, mild, moderate 
and severe malnutrition, respectively. The protocol was 
approved by the ethics committee of our institution, and 
informed consent was obtained from each parent or relative 
in charge of the care of the patient.
Sleep study
All participants were submitted to full hospital-based 
overnight polysomnography using an EMBLA digital 
system (16 channels, Flaga hf. Medical Devices). No 
sedation or sleep deprivation was used to induce sleep. The 
following variables were monitored: electroencephalogram 
(EEG) four channels: C3-A2, C4-A1, O1-A2 and O2-A1; 
electrooculogram (EOG) two channels: LOC-A1 and ROC 
–A1; electromyogram (EMG) two channels: submental 
and anterior tibial muscles using surface electrodes; 
electrocardiogram (ECG) one channel; and snoring and 
body position were detected with EMBLA sensors. A 
thermocouple transducer was used to detect airflow. Chest 
and abdominal piezo sensors monitored respiratory effort. 
Oxygen saturation (SaO2) and pulse were recorded with 
a pulse oximeter (EMBLA). All polysomnograms were 
recorded and scored based on guidelines for sleep studies 
(Rechtschaffen & Kales). Arousals were defined as shifts 
to increased EEG frequencies for ³3 seconds. Apneas were 
defined as at least two respiratory cycles in length and 
associated with oxygen desaturation >4% from baseline or 
an arousal; hypopnea was defined as two missed breaths, 
≥ 50% fall in amplitude and >3% desaturation associated 
or not associated with arousal (AASM Manual, 2007).10 
Obstructive apnea was defined as an absence of oronasal 
airflow despite continued out-of-phase chest and abdominal 
movements. Mixed apnea was defined as absence of oronasal 
airflow associated with central followed by obstructive 
components. The number of apneas and hypopneas per hour 
of sleep defined the apnea-hypopnea index (AHI). Periodic 
breathing was characterized by the presence of three or 
more consecutive respiratory pauses of three seconds or 
longer, interposed with periods of ventilation of less than 
20 seconds.
Statistical analysis
Due to the small sample size, all parameters were 
assumed to have non-parametric distributions. The 
descriptive data are given as medians (25-75% range), and 
comparisons were made using a Kruskal-Wallis one-way 
analysis of variance on ranks with a Tukey post-hoc test. 
P-values of <0.05 were considered statistically significant. 
RESULTS
The origins of the 14 CHD infants studied are presented 
in Table 1. In general, the cyanotic CHD infants presented 
complex CHD defects. The demographic characteristics 
as well as the resting cardiac and respiratory rates of the 
entire study population are described in Table 2. Despite the 
relatively narrow age range adopted as an entry criterion, 
CHD patients were younger than controls (p = 0.017) and 
were significantly so in the group of cyanotic infants. The 
CHD infants presented moderate-to-severe malnutrition 
(Table 2). 1207
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All CHD patients were stable when the sleep study was 
performed and slept for at least six hours. The main results 
derived from polysomnography studies are presented in 
Table 3. 
Cyanotic CHD infants had increased wakefulness times 
with consequent decreased sleep efficiencies. However, 
there were no significant differences in sleep architecture 
or arousals between groups. As expected, the mean oxygen 
saturation during sleep (SaO2) and the minimum oxygen 
saturation were lower in cyanotic infants. Almost all CHD 
infants (11 of 14) demonstrated an AHI >1 event/hour. By 
contrast, only one healthy infant had an AHI >1 event/
hour. This particular infant had no obstructive apnea but 
exhibited 13 hypopneas and 5 central apneas with minimal 
SaO2 of 90%, which was in the normal range. The majority 
of respiratory events among CHD infants were represented 
by central apnea or hypopnea. Only one CHD infant had 
more than one obstructive apnea (10 out of a total of 43 
events). The durations of the central apneas in CHD and 
control infants were similar (6.99 ±1.24 s and 7.70 ±0.62 s, 
respectively; p=0.253) and varied from 5 to 13 s and from 
6 to 18 s, respectively. No infants had obstructive apneas 
>10 s in duration (range: 4–9 s) or periodic breathing. The 
respiratory hypopneas occurred predominantly during Rapid 
Eye Movement (REM) sleep. In our study, we observed that 
CHD patients frequently experienced central apneas during 
sleep, which were associated with hypoxia and oscillations 
in cardiac frequency. 
DISCUSSION
The present study was designed to investigate the 
pattern of sleep in patients with CHD. We found that CHD 
infants frequently presented central hypopneas and apneas 
during sleep. These respiratory events were associated with 
significant oxygen desaturation, particularly in cyanotic 
CHD infants. However, as expected for this age range, the 
respiratory events were not associated with arousals.11 
Our results confirm those of a previous study using 
limited respiratory monitoring without EEG, which also 
showed frequent oxygen desaturation during sleep in CHD 
infants.5 Our study extends these findings by showing that 
increased wakefulness time after sleep onset resulted in 
decreased sleep efficiency in cyanotic CHD infants, which 
was intermediate in acyanotic CHD infants compared to 
normal controls. The decreased sleep efficiency in cyanotic 
CHD infants could be related to persistent hypoxia or a more 
severe underlying cardiac disease, which is characteristic of 
cyanotic CHD infants (Table 2). Our study also showed that 
despite an increased AHI in CHD infants, the respiratory 
events were not associated with increased arousals. The lack 
of difference in arousal indices among the three groups is not 
surprising, considering that the lower spontaneous arousal 
indices are usually not altered among children with SDB.12 
Table 1 - Diagnoses in congenital heart defects, according to 
SaO2 above (Acyanotic) and below (Cyanotic) 90%
Number of cases
Acyanotic
VSD 2
VSD + Atrial septal defect 1
Patent ductus arteriosus 2
Aortic coarctation + Atrial septal defect 1
Corrected transposition of the great arteries + VSD 1
Cyanotic
Transposition of the great arteries + VSD 3
Tricuspid atresia Type I C 1
Persistent truncus arteriosus  2
Double-outlet right ventricle + VSD 1
VSD, ventricular septal defect.
Table 2 - Demographic and physiological characteristics of the population studied. Data are presented as mean ± SD or 
median (25-75% inter-quartile range)
CHD Acyanotic (n=7) CHD Cyanotic (n=7) Control (n=7) P
Age, months 7.8 ± 1.9 6.9 ± 1.5 * 10.0 ± 1.5 0.011
Height, cm 66 ± 4 60 ± 6* 72 ± 5 0.001
Weight, Kg 6.9 ± 0.7* 4.7 ± 0.9* 8.7 ± 0.1 <0.001
Goméz, % 70 ± 7* 59 ± 11* 94 ± 16 <0.001
SaO2, % 95 (94-96) 85 (78-86) 97 (96-98) <0.001
Cardiac rate, cycles/min 130 ± 11 140 ±9* 124 ± 8 0.020
Respiratory rate, breaths/min 49 ± 6*p 66 ± 13* 25 ± 2 <0.001
CHD, congenital heart defects. *Different from control, **Different between cyanotic and acyanotic CHD groups, Goméz = weight X 100/ideal weight. 
The p-value corresponds to the comparison of the three groups; n corresponds to the number of infants studied in each group.1208
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The arousal index in the control group was similar to what 
has been previously reported in this age range (6.5/h and 
7-9/h)4 and was not significantly different from the CHD 
infants (approx. 9/h, Table 2). The low level of arousals in 
children with SDB4 contrasts with what is found in adults. 
This may reflect the inability of children to awaken when 
faced with potentially life-threatening respiratory events. 
The role of hypoxemia during sleep in infants with 
CHD and its effects on the development of pulmonary 
hypertension have not been investigated5. However, sustained 
hypoxia and hyperflow may contribute to the development of 
pulmonary hypertension in infants with CHD.13,14 Therefore, 
our data showing intermittent hypoxia over and above 
sustained hypoxia in cyanotic CHD raise the possibility that 
recurrent central apneas may contribute to the development 
of pulmonary hypertension. The oxygen desaturations that 
occurred in the absence of arousals in our study may also be 
relevant. The main cause of death in children under one year 
of age is sudden infant death syndrome (SIDS),15 in which 
the cause of death remains unexplained after a thorough 
post-mortem examination. Notably, a significant proportion 
of sudden infant death is associated with CHD, including 
isolated ventricular septal defects16 and ductus-dependent, 
complex and cyanotic CHD.17 Malignant arrhythmias 
triggered by sleep-related hypoxemia may be an important 
mechanism leading to death. For instance, Dancea et al. 
found in a case series of sudden infant death that a large 
proportion of the infants were stable at home and died 
unexpectedly during sleep.16 Delayed resetting of peripheral 
chemoreceptors has been demonstrated in chronically 
hypoxic kittens and preterm infants with bronchopulmonary 
dysplasia.5 Because peripheral chemoreceptors play a key 
role in initiating ventilatory, cardiovascular and arousal 
responses to hypoxia, we speculate that this delay may 
be among the factors that place cyanotic CHD infants at 
greater risk for SIDS. The observation of bradycardia and 
tachycardia associated with central apneas could represent 
a sympatho-vagal imbalance, a mechanism potentially 
involved in the genesis of arrhythmias.17 
There are multiple reasons for oxygen desaturation 
during sleep in infants with CHD. Compared to adults, 
healthy infants have a greater chest wall compliance, 
which predisposes them to breathing at a lower relative 
lung volume than adults, resulting in airway closure, 
more lung units with a low ventilation/perfusion ratio and 
more intrapulmonary shunting18. These differences may 
become more pronounced during sleep and may predispose 
infants to greater ventilation-perfusion mismatching and 
greater oxygen desaturation than adults. Infants with CHD 
have decreased respiratory compliance (associated with 
Table 3 - Polysomnography data of the population studied. Data are presented as mean ± SD or median (25-75% inter-
quartile range)
CHD Acyanotic (n=7) CHD Cyanotic (n=7) Control (n=7) P
Total sleep time, minutes 424 ± 57 395 ± 43 449 ± 37 0.127
Wakefulness time, min 95 ± 42 116 ± 47* 60 ± 15 0.038
Sleep efficiency, % 82 ± 7 77 ± 8* 88 ± 3 0.022
Arousal Index, events/hr 8.4 ± 2.4 10.3 ± 8.7 6.5 ± 3.1 0.451
S1 + S2, % 46 ± 9 44 ± 10 42 ± 10 0.547
S3 + S4, % 36 ± 12 39 ± 6 39 ± 3 0.371
REM, % 15 ± 6 16 ± 10 19 ± 7 0.699
AHI, events/hr 2.5 (1.0-3.4)* 2.4 (1.5-3.1)* 0.7 (0.7-0.9) 0.013
Obstructive apneas 0 (0 - 1) 0 (0-0) 0 (0–1) 0.191
Central apneas 5 (1 – 7) 5 (0 –8) 3 (1-4) 0.975
Hypopneas 17 (6–25)* 14 (5–16)* 3 (1–5) 0.023
SaO2 Mean, % 94 ± 2** 85 ± 5* 96 ± 2 <0.001
SaO2 Minimum, % 79 (74–82) ** 73 (57–74)* 90 (90–91) <0.001
AHI REM 1.3 ± 1.4 0.7 ± 1.2 0.5 ± 0.3 0.345
AHI nREM 1.0 (0.5-2.3) 0.3 (0.05-2.3) 0.2 (0.02-0.5) 0.076
SaO2 min REM 83 ± 4** 75 ± 7* 89 ± 1 <0.001
SaO2 min nREM 81 ± 5 76 ± 5* 91 ± 1  <0.001
*Different from control group, **Different between acyanotic and cyanotic groups. SaO2 mean and minimum oxygen saturation during sleep, respectively. 
S1, S2, S3 and S4 correspond to Stage 1, Stage 2, Stage 3 and Stage 4 of sleep, respectively. The p-value corresponds to the comparison of the three groups. 
Significant differences between groups (p <0.05) are indicated with symbols.1209
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decreased tidal volume and increased respiratory rate), 
findings that are consistent with restrictive pulmonary 
disease.5 Adult patients with restrictive pulmonary disease 
of various causes experience oxygen desaturation during 
sleep.19 The restrictive pulmonary disease in CHD infants 
may be a result of increased pulmonary artery pressure, 
which may be associated with congestive heart failure and 
pulmonary edema. CHD infants typically demonstrate a 
high resting respiratory rate (Table 2), which may result in 
a disproportionate increase in dead space ventilation during 
sleep. In addition to these mechanisms, the increased AHI 
observed in CHD infants may also contribute to oxygen 
desaturation during sleep. 
The reasons for increased central apneas and hypopneas 
in CHD infants were not explored in this work. Whereas 
ventilation is under the influence of several factors during 
wakefulness, during sleep, ventilation is under chemical-
metabolic control. For ventilation to be maintained, it 
is necessary that PaCO2 stay above the apnea threshold; 
therefore, hyperventilation and the resultant hypocapnia 
are thought to be the major abnormalities contributing to 
ventilatory control instability.20 In adults with congestive 
heart failure, central apneas in association with Cheyne-
Stokes respiration are common. In adults, Cheyne-Stokes 
respiration is also associated with hyperventilation and 
hypocapnia.6 In our study, CHD infants demonstrated 
tachypnea, but unfortunately, we did not monitor arterial CO2 
levels. Of note, no CHD infants exhibited either Cheyne-
Stokes respiration or periodic breathing in association 
with central apneas or hypopneas. The absence of a 
typical Cheyne-Stokes pattern of breathing may be related 
to a different pattern of cardiovascular and pulmonary 
involvement in these infants. 
Our study has some limitations. First, we studied a small 
number of subjects, making it difficult to draw definitive 
conclusions. Second, we studied infants in different 
age ranges; that variation, however, does not affect the 
respiratory findings. CHD infants were also malnourished. 
Because malnourished infants have shorter bouts of 
sustained sleep,21 the increased wakefulness found in CHD 
infants could be related to nutritional status rather than to 
central apneas. Finally, although infants using medications 
that potentially affect the CNS were excluded, the use of 
cardiovascular drugs could also have affected sleep. 
In conclusion, CHD patients are prone to sleep-related 
oxygen desaturations, central apneas and hypopneas that are 
not associated with arousals. Although sleep may represent 
an additional burden to these infants, it has rarely been 
studied. Therefore, this study provides a strong rationale 
for investigating sleep disordered breathing in CHD infants.
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